| # | Company | Location | Employees | Total Funding | Last Round | Last Funded |
|---|---|---|---|---|---|---|
| 1 |
Function Health
Function Health is a health platform offering lab tests to help individuals moni…
|
Austin | — | $354.0M | Series B | 2025-11-19 |
| 2 |
Ceribell
Ceribell focuses on making electroencephalography accessible, efficient, and cos…
|
Mountain View | 251 - 500 | $171.0M | Series C | 2022-09-21 |
| 3 |
Doctronic
Doctronic is the #1 AI doctor delivering secure, accurate, and instant medical g…
|
New York | 51 - 100 | $65.0M | Series B | 2026-03-23 |
| 4 |
Freenome
Freenome is a biotechnology company developing blood tests for early cancer dete…
|
South San Francisco | 251 - 500 | $1.5B | Corporate Round | 2025-11-17 |
| 5 |
BillionToOne
BillionToOne is a precision diagnostics company that focuses on genetic testing …
|
Menlo Park | 501 - 1K | $425.9M | Series D | 2024-06-21 |
| 6 |
Overjet
Overjet is a software development company that offers an AI platform for dentist…
|
Boston | 101 - 250 | $155.9M | Series Unknown | 2025-12-08 |
| 7 |
Century Therapeutics
Century Therapeutics is a biotechnology company that develops cell therapies for…
|
Philadelphia | 101 - 250 | $755.0M | Post Ipo Equity | 2026-01-08 |
| 8 |
Teal Health
Teal Health is a health tech company that develops cervical cancer screening and…
|
San Francisco | 11 - 50 | $21.5M | Seed | 2025-01-16 |
| 9 |
ImmunityBio
ImmunityBio is a late-stage immunotherapy startup that is developing treatments …
|
Culver City | 501 - 1K | $1.4B | Post Ipo Equity | 2025-07-25 |
| 10 |
Heartflow
Heartflow is a medical technology company that provides various methods of diagn…
|
Mountain View | 501 - 1K | $890.7M | Convertible Note | 2025-03-26 |
| 11 |
Parallel Health
Parallel is a next-generation skin health company providing derm telehealth, ski…
|
San Francisco | 1 - 10 | $1.9M | Grant | 2022-09-20 |
| 12 |
Fountain Life
Fountain Life is a preventative health and longevity company that offers AI-powe…
|
Naples | 101 - 250 | $115.1M | Series B | 2025-08-13 |
| 13 |
Genelux
Genelux is a biopharmaceutical company that develops diagnostic and therapeutic …
|
Westlake Village | 11 - 50 | $129.5M | Post Ipo Equity | 2026-01-09 |
| 14 |
Notable
Notable is the AI platform for healthcare operations.
|
San Mateo | 251 - 500 | $119.2M | Series B | 2021-11-03 |
| 15 |
Truvian Sciences
Truvian Sciences develops an automated benchtop system to provide lab-accurate b…
|
San Diego | 101 - 250 | $208.1M | Series D | 2024-07-17 |
| 16 |
Oxford Nanopore Technologies
Oxford Nanopore Technologies is a biotechnology company that develops and commer…
|
Oxford | 1K - 5K | $1.6B | Post Ipo Equity | 2024-08-01 |
| 17 |
Element Biosciences
Element Biosciences is a life science company that focuses on developing innovat…
|
San Diego | 251 - 500 | $678.0M | Series D | 2024-07-11 |
| 18 |
Hilo
Hilo is a healthcare company that provides blood pressure, digital therapeutics,…
|
Neuchâtel | 51 - 100 | $101.7M | Series B | 2025-05-01 |
| 19 |
Qure AI
Qure AI is a healthcare technology company that provides automated interpretatio…
|
Andheri | 251 - 500 | $133.3M | Grant | 2026-01-22 |
| 20 |
Hormona
Hormona is a healthtech startup that utilizes AI and at-home testing to help wom…
|
London | 11 - 50 | $8.8M | Grant | 2025-09-10 |
| 21 |
Superpower
Superpower offers a digital health platform that integrates comprehensive diagno…
|
Los Angeles | 11 - 50 | $34.0M | Series A | 2025-04-22 |
| 22 |
BrainCheck
BrainCheck is a digital platform for cognitive assessment and care that evaluate…
|
Houston | 101 - 250 | $54.7M | Series A | 2026-02-26 |
| 23 |
Grail
Grail is a healthcare company that develops pan-cancer screening tests designed …
|
Menlo Park | 501 - 1K | $2.4B | Post Ipo Equity | 2025-10-20 |
| 24 |
Pearl
Pearl is the global leader in dental AI, powering diagnosis, care, and practice …
|
West Hollywood | 101 - 250 | $69.0M | Series B | 2024-07-24 |
| 25 |
Visby Medical
Visby Medical is a diagnostics company that develops polymerase chain reaction d…
|
San Jose | 101 - 250 | $435.8M | Series Unknown | 2025-06-17 |
| 26 |
Roche
Roche is a pharmaceutical and diagnostics company that offers medicines and diag…
|
Basel | c 10001 max | $7.8B | Post Ipo Equity | 2021-08-04 |
| 27 |
Valencia Technologies
Valencia Technologies is a neuromodulation company that develops implantable sys…
|
Valencia | 101 - 250 | $46.0M | Series Unknown | 2025-02-20 |
| 28 |
GE Healthcare
GE Healthcare provides a wide range of medical technologies and services to heal…
|
Chicago | c 10001 max | $5.5B | Post Ipo Secondary | 2024-11-07 |
| 29 |
Practo
Practo is an mhealth platform that connects patients with healthcare providers t…
|
Bangalore | 501 - 1K | $228.2M | Series D | 2020-08-15 |
| 30 |
Curative
Curative provides employer-based health insurance plans and healthcare services.
|
Austin | 501 - 1K | $158.0M | Series B | 2025-11-28 |
| 31 |
GlycanAge
Our vision is to make preventive and personalised healthcare the standard of car…
|
Newcastle Upon Tyne | 11 - 50 | $14.0M | Series Unknown | 2025-12-18 |
| 32 |
Lunit
Lunit is a medical technology company that specializes in developing and providi…
|
Seoul | 251 - 500 | $560.7M | Post Ipo Debt | 2024-05-07 |
| 33 |
Bunkerhill Health
Ask anything about your patients. Automate what happens next.
|
Palo Alto | 11 - 50 | $30.0M | Series A | 2023-07-01 |
| 34 |
Altos Labs
Altos Labs focuses on cellular rejuvenation programming to restore cell health a…
|
San Francisco | 251 - 500 | $3.0B | Series A | 2021-09-06 |
| 35 |
Inito
Inito is a developer of a medical testing device designed to facilitate accurate…
|
Palo Alto | 51 - 100 | $42.5M | Series B | 2025-12-10 |
| 36 |
Ultromics
Ultromics develops AI-driven cardiology solutions to assist in cardiovascular di…
|
Oxford | 101 - 250 | $113.8M | Series Unknown | 2025-12-17 |
| 37 |
GeneDx
GeneDx uses artificial intelligence and machine learning to analyze patient data…
|
Stamford | 501 - 1K | $941.0M | Post Ipo Equity | 2023-01-26 |
| 38 |
Linus Health
Linus Health is a digital health company focused on improving mental health and …
|
Waltham | 101 - 250 | $64.9M | Series B | 2021-07-06 |
| 39 |
Elephas
Elephas harnesses latest advances in cancer biology, multimodal microscopy, and …
|
Madison | 101 - 250 | $163.5M | Series Unknown | 2025-11-06 |
| 40 |
Carna Health
Carna Health is a biotech company that brings common clinical whole blood tests …
|
Boston | 11 - 50 | $11.4M | Seed | 2026-01-08 |
| 41 |
Eyebot
Eyebot develops an eye examination technology to eliminate barriers and provide …
|
Boston | 11 - 50 | $29.9M | Series A | 2025-08-26 |
| 42 |
Beacon Biosignals
Beacon Biosignals is a neurotechnology company that brings precision neuroscienc…
|
Boston | 51 - 100 | $116.0M | Series B | 2025-11-13 |
| 43 |
Navina
Navina develops an AI-driven platform that restructures patient data into intuit…
|
New York | 101 - 250 | $99.0M | Series C | 2025-03-25 |
| 44 |
Natera
Natera specializes in cell-free DNA testing to provide a more targeted intervent…
|
San Carlos | 1K - 5K | $1.2B | Post Ipo Equity | 2023-09-07 |
| 45 |
Anumana
Anumana develops AI-driven ECG algorithms for early cardiovascular diagnosis and…
|
Cambridge | 101 - 250 | $117.7M | Series C | 2025-04-24 |
| 46 |
Paradigm
Paradigm creates a platform that allow all patients to participate in clinical t…
|
New York | 101 - 250 | $281.0M | Series B | 2025-12-04 |
| 47 |
Kestra Medical Technologies, Inc.
Kestra Medical Technologies offers wearable medical devices which collects, stor…
|
Kirkland | 101 - 250 | $334.0M | Post Ipo Equity | 2025-12-02 |
| 48 |
Janux Therapeutics
Janux Therapeutics develops immunotherapies that generates immune responses to p…
|
La Jolla | 101 - 250 | $898.9M | Post Ipo Equity | 2024-12-03 |
| 49 |
Ahead Health
Ahead Health is redefining preventive healthcare by making personalized health i…
|
Z├╝rich | — | $6.0M | Seed | 2026-01-13 |
| 50 |
Spectrawave
Spectrawave is a medical device company that develops optical diagnostic and the…
|
Waltham | 51 - 100 | $79.6M | Series B | 2024-09-11 |